Mankind’s endeavour to create generic formulations is inspired by its philosophy of providing affordable healthcare to all sections of the society. We offer more than 100 high-quality affordable generic versions of expensive innovator medicines. Mankind’s commitment is paramount for bringing quality and innovation into its pharmaceutical products.
Mankind’s formulation and research is an amalgamation of a well-seasoned team of proficient and experienced scientists, technicians, and chemists who work relentlessly to solve tough challenges and provide innovative solutions for patients around the globe. To benefit patients and deliver the intellectual property to the organization, Mankind continually strives to discover the engineering solution of drug therapies in order to improve the safety and efficacy of its products.
Expanding further, Mankind is developing products for global markets including the USA.
Currently, Mankind is working on enhancing the bioavailability of molecules which may lead to a reduction in dose while increasing the safety profile of its drugs.
Mankind develops generic products of various dosage forms as mentioned below:
-
TabletsMultilayer tablets, compression-coated tablets and inlay tablets
-
CapsulePellets of immediate-release, sustained-release and delayed-release
-
Liquid OralsSyrups and suspensions
-
Topical ProductsOintments, creams and gel preparations
-
TechnologyTaste-masking technology
-
SyrupDry syrup technologies
-
EffervescentEffervescent technologies
-
ParenteralsSterile preparations
-
OphthalmicsIncluding nano-emulsion technologies
Mankind’s therapeutic product portfolio includes formulations from Antibiotics, CVS, CNS, Anti-asthma, Anti-TB, Diabetology, Dermatology, Gastro-intestinal, which have been trusted by patients and doctors across the globe.
team ensures:
- Optimization of process based on scientific principals and positive identification of Critical Process Parameters (CPPs) & Critical Quality Attributes (CQAs).
- Variability of process and parameters are controlled and sufficient in the face of the rigors of a commercial production environment.